VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN for Immunisation: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 123 adverse event reports in the FDA FAERS database where VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN was used for Immunisation.
Most Reported Side Effects for VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| No adverse event | 772 | 38.6% | 0 | 0 |
| Product storage error | 330 | 16.5% | 1 | 0 |
| Drug ineffective | 245 | 12.2% | 4 | 45 |
| Herpes zoster | 209 | 10.4% | 9 | 39 |
| Diarrhoea | 135 | 6.7% | 2 | 37 |
| Nausea | 133 | 6.6% | 0 | 27 |
| Drug intolerance | 125 | 6.2% | 0 | 17 |
| Expired product administered | 125 | 6.2% | 0 | 2 |
| Pruritus | 119 | 5.9% | 0 | 22 |
| Pyrexia | 119 | 5.9% | 11 | 37 |
| Hypersensitivity | 109 | 5.4% | 0 | 23 |
| Pain | 105 | 5.2% | 16 | 37 |
| Vaccination failure | 102 | 5.1% | 10 | 26 |
| Lymphoma | 101 | 5.0% | 0 | 1 |
| Off label use | 99 | 5.0% | 2 | 39 |
Other Indications for VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN
Prophylaxis (1,444)
Product used for unknown indication (270)
Routine health maintenance (49)
Rheumatoid arthritis (38)
Varicella immunisation (34)
Herpes zoster (26)
Herpes zoster immunisation (5)
Other Drugs Used for Immunisation
INFLUENZA VIRUS VACCINE (560)
PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (281)
COVID-19 VACCINE NOS (269)
TOZINAMERAN (207)
MEASLES VIRUS STRAIN ENDERS^ ATTENUATED EDMONSTON LIVE ANTIGEN\MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN\RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN (152)
TUBERCULIN PURIFIED PROTEIN DERIVATIVE (148)
PNEUMOCOCCAL VACCINE POLYVALENT (140)
AD26.COV2.S (113)
STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE A (111)
MENINGOCOCCAL POLYSACCHARIDE VACCINE A\NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN (110)